Plans to seek regulatory approval to commence a Phase III trial in the US and Canada VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ -- Sustained Therapeutics Inc. ("Sustained Therapeutics" or the "Company") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback